3983 — China BlueChemical Balance Sheet
0.000.00%
- HK$10.83bn
- -HK$373.60m
- CNY11.95bn
- 73
- 92
- 93
- 99
Annual balance sheet for China BlueChemical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10,165 | 11,231 | 12,546 | 13,191 | 13,510 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 884 | 654 | 597 | 511 | 629 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12,685 | 13,462 | 15,485 | 15,577 | 15,356 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,533 | 6,743 | 7,038 | 7,143 | 7,177 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,748 | 21,432 | 23,498 | 24,317 | 24,076 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,903 | 3,442 | 4,103 | 3,144 | 2,513 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,048 | 5,604 | 6,751 | 6,016 | 5,668 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 14,700 | 15,827 | 16,747 | 18,301 | 18,408 |
| Total Liabilities & Shareholders' Equity | 20,748 | 21,432 | 23,498 | 24,317 | 24,076 |
| Total Common Shares Outstanding |